Consolidated Balance Sheets - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Loans held for investment	$ 331,075,547	$ 196,984,566
Current expected credit loss reserve	(1,497,933)	(134,542)
Loans held for investment at carrying value, net	329,577,614	196,850,024
Cash	9,331,530	80,248,526
Interest receivable	727,279	197,735
Other receivables and assets, net	844,486	874,170
Total Assets	340,480,909	278,170,455
Liabilities
Revolving Loan	53,000,000
Dividend payable	8,435,222	4,537,924
Interest reserve	5,625,979	6,636,553
Management and incentive fees payable	1,347,421	802,294
Related party payable	1,203,030	1,902,829
Accounts payable and other liabilities	716,463	212,887
Total Liabilities	70,328,115	14,092,487
Commitments and contingencies (Note 8)
Stockholders’ equity
Common stock, par value $0.01 per share, 100,000,000 shares authorized at September 30, 2022 and December 31, 2021, respectively, and 17,742,915 and 17,453,553 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	176,579	173,551
Additional paid-in-capital	268,888,861	264,081,977
Accumulated earnings (deficit)	1,087,354	(177,560)
Total stockholders’ equity	270,152,794	264,077,968
Total liabilities and stockholders’ equity	$ 340,480,909	$ 278,170,455